Atlas Trials

Immunonutritional Supplement After Total Gastrectomy in Patients With Stage III Gastric Cancer

Clinical trial NCT05253716 · UNKNOWN

Trial details

NCT number
NCT05253716
Sponsor
Jinling Hospital, China
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Stage III Gastric Cancer
Start date
2022-08-01
Primary completion
2026-03-01
Enrollment
696

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.